$2.43 Billion is the total value of Deep Track Capital, LP's 58 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 63.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| JAZZ | Buy | JAZZ PHARMACEUTICALS PLC | $175,596,000 | +26.2% | 1,200,000 | +37.4% | 7.21% | +23.4% |
| ISEE | Sell | IVERIC BIO INC | $158,145,000 | -6.2% | 6,500,000 | -17.5% | 6.50% | -8.3% |
| TVTX | Buy | TRAVERE THERAPEUTICS INC | $138,252,057 | +43.5% | 6,147,268 | +34.2% | 5.68% | +40.3% |
| IMVT | Sell | IMMUNOVANT INC | $115,281,441 | -33.1% | 7,432,717 | -23.5% | 4.74% | -34.6% |
| INSM | Buy | INSMED INC | $110,825,000 | +30.1% | 6,500,000 | +52.4% | 4.55% | +27.3% |
| IONS | Buy | IONIS PHARMACEUTICALS INC | $101,289,626 | +122.4% | 2,834,069 | +135.0% | 4.16% | +117.6% |
| ITCI | New | INTRA-CELLULAR THERAPIES INC | $92,055,000 | – | 1,700,000 | +100.0% | 3.78% | – |
| PLRX | Buy | PLIANT THERAPEUTICS INC | $91,026,716 | +171.7% | 3,422,057 | +97.5% | 3.74% | +165.9% |
| ALKS | New | ALKERMES PLC | $84,570,000 | – | 3,000,000 | +100.0% | 3.47% | – |
| SWTX | Sell | SPRINGWORKS THERAPEUTICS INC | $79,794,000 | -1.4% | 3,100,000 | -0.3% | 3.28% | -3.5% |
| KDNY | CHINOOK THERAPEUTICS INC | $69,450,000 | -11.6% | 3,000,000 | 0.0% | 2.85% | -13.6% | |
| RETA | New | REATA PHARMACEUTICALS INCcl a | $66,280,680 | – | 729,000 | +100.0% | 2.72% | – |
| VRNA | VERONA PHARMA PLCsponsored ads | $64,003,293 | -23.2% | 3,187,415 | 0.0% | 2.63% | -24.8% | |
| New | STRUCTURE THERAPEUTICS INCsponsored ads | $62,966,936 | – | 2,646,782 | +100.0% | 2.59% | – | |
| DVAX | Buy | DYNAVAX TECHNOLOGIES CORP | $62,293,500 | +151.5% | 6,350,000 | +172.8% | 2.56% | +146.0% |
| BCYC | BICYCLE THERAPEUTICS PLCsponsored ads | $59,961,087 | -28.1% | 2,819,045 | 0.0% | 2.46% | -29.7% | |
| GERN | Buy | GERON CORP | $58,302,429 | +224.9% | 26,867,479 | +262.4% | 2.40% | +218.1% |
| BIIB | Sell | BIOGEN INC | $55,606,000 | -33.1% | 200,000 | -33.3% | 2.28% | -34.5% |
| Sell | DICE THERAPEUTICS INC | $45,840,000 | -15.3% | 1,600,000 | -7.7% | 1.88% | -17.1% | |
| AGEN | Buy | AGENUS INC | $45,600,000 | -29.6% | 30,000,000 | +11.1% | 1.87% | -31.2% |
| SGEN | New | SEAGEN INCput | $44,097,966 | – | 217,800 | +100.0% | 1.81% | – |
| PACB | New | PACIFIC BIOSCIENCES CALIF IN | $40,580,836 | – | 3,504,390 | +100.0% | 1.67% | – |
| FDMT | Sell | 4D MOLECULAR THERAPEUTICS IN | $39,160,659 | -33.6% | 2,278,107 | -14.3% | 1.61% | -35.1% |
| BEAM | Buy | BEAM THERAPEUTICS INC | $38,275,000 | -16.1% | 1,250,000 | +7.2% | 1.57% | -17.9% |
| EXEL | New | EXELIXIS INC | $37,497,674 | – | 1,931,874 | +100.0% | 1.54% | – |
| ARGX | New | ARGENX SEput | $37,258,000 | – | 100,000 | +100.0% | 1.53% | – |
| VRDN | Sell | VIRIDIAN THERAPEUTICS INC | $31,297,789 | -39.5% | 1,230,259 | -30.5% | 1.28% | -40.8% |
| AUTL | AUTOLUS THERAPEUTICS PLCspon ads | $27,600,000 | -3.2% | 15,000,000 | 0.0% | 1.13% | -5.3% | |
| ETNB | Sell | 89BIO INC | $27,414,000 | -44.1% | 1,800,000 | -53.2% | 1.13% | -45.3% |
| DYN | Sell | DYNE THERAPEUTICS INC | $26,894,972 | -13.5% | 2,334,633 | -13.0% | 1.10% | -15.4% |
| RPTX | REPARE THERAPEUTICS INC | $26,839,643 | -33.1% | 2,727,606 | 0.0% | 1.10% | -34.6% | |
| NRIX | Buy | NURIX THERAPEUTICS INC | $26,620,730 | +7.0% | 2,997,830 | +32.3% | 1.09% | +4.6% |
| NTLA | Buy | INTELLIA THERAPEUTICS INC | $26,257,945 | +7.5% | 704,533 | +0.6% | 1.08% | +5.2% |
| ASTRIA THERAPEUTICS INC | $24,159,862 | -10.7% | 1,816,531 | 0.0% | 0.99% | -12.7% | ||
| DCPH | New | DECIPHERA PHARMACEUTICALS IN | $21,061,455 | – | 1,363,201 | +100.0% | 0.86% | – |
| EWTX | Sell | EDGEWISE THERAPEUTICS INC | $20,465,288 | -32.2% | 3,068,259 | -9.1% | 0.84% | -33.6% |
| Sell | VIGIL NEUROSCIENCE INC | $19,826,091 | -24.6% | 2,025,137 | -3.8% | 0.81% | -26.3% | |
| INZY | INOZYME PHARMA INC | $18,622,500 | +445.7% | 3,250,000 | 0.0% | 0.76% | +435.0% | |
| QURE | New | UNIQURE NV | $17,436,547 | – | 865,767 | +100.0% | 0.72% | – |
| PNT | New | POINT BIOPHARMA GLOBAL INC | $17,048,681 | – | 2,345,073 | +100.0% | 0.70% | – |
| ABOS | ACUMEN PHARMACEUTICALS INC | $16,045,120 | -24.8% | 3,952,000 | 0.0% | 0.66% | -26.5% | |
| ALLK | Sell | ALLAKOS INC | $15,953,250 | -61.3% | 3,585,000 | -26.8% | 0.66% | -62.2% |
| ACRS | New | ACLARIS THERAPEUTICS INC | $13,825,575 | – | 1,708,971 | +100.0% | 0.57% | – |
| NUVB | Sell | NUVATION BIO INC | $12,816,342 | -18.8% | 7,720,688 | -6.1% | 0.53% | -20.7% |
| SLN | SILENCE THERAPEUTICS PLCads | $12,099,796 | -59.3% | 1,951,580 | 0.0% | 0.50% | -60.2% | |
| RAPT | Sell | RAPT THERAPEUTICS INC | $10,482,126 | -59.4% | 571,233 | -56.2% | 0.43% | -60.3% |
| JNCE | JOUNCE THERAPEUTICS INC | $7,880,358 | +66.7% | 4,259,653 | 0.0% | 0.32% | +62.8% | |
| RLMD | RELMADA THERAPEUTICS INC | $6,413,469 | -35.2% | 2,837,818 | 0.0% | 0.26% | -36.8% | |
| New | ORCHARD THERAPEUTICS PLCspon ads new | $6,265,018 | – | 1,166,670 | +100.0% | 0.26% | – | |
| HRTX | Sell | HERON THERAPEUTICS INC | $4,884,430 | -69.9% | 3,234,722 | -50.2% | 0.20% | -70.5% |
| NKTX | NKARTA INC | $4,807,410 | -40.7% | 1,354,200 | 0.0% | 0.20% | -42.2% | |
| GHRS | GH RESEARCH PLCordinary shares | $3,990,206 | -17.8% | 499,400 | 0.0% | 0.16% | -19.6% | |
| IMUX | New | IMMUNIC INC | $3,761,121 | – | 2,524,242 | +100.0% | 0.15% | – |
| New | 2SEVENTY BIO INC | $3,570,000 | – | 350,000 | +100.0% | 0.15% | – | |
| IPSC | Buy | CENTURY THERAPEUTICS INC | $3,549,435 | -0.6% | 1,022,892 | +47.0% | 0.15% | -2.7% |
| IMGN | New | IMMUNOGEN INCput | $1,643,904 | – | 428,100 | +100.0% | 0.07% | – |
| NKTR | New | NEKTAR THERAPEUTICS | $1,225,329 | – | 1,743,248 | +100.0% | 0.05% | – |
| ETNB | New | 89BIO INCput | $67,012 | – | 4,400 | +100.0% | 0.00% | – |
| RETA | Exit | REATA PHARMACEUTICALS INCcall | $0 | – | -12,600 | -100.0% | -0.02% | – |
| HOOK | Exit | HOOKIPA PHARMA INC | $0 | – | -1,240,369 | -100.0% | -0.04% | – |
| MGTA | Exit | MAGENTA THERAPEUTICS INC | $0 | – | -3,000,000 | -100.0% | -0.05% | – |
| AUPH | Exit | AURINIA PHARMACEUTICALS INC | $0 | – | -324,238 | -100.0% | -0.06% | – |
| Exit | THIRD HARMONIC BIO INC | $0 | – | -445,572 | -100.0% | -0.08% | – | |
| ASMB | Exit | ASSEMBLY BIOSCIENCES INC | $0 | – | -1,833,437 | -100.0% | -0.10% | – |
| FULC | Exit | FULCRUM THERAPEUTICS INC | $0 | – | -768,607 | -100.0% | -0.24% | – |
| VKTX | Exit | VIKING THERAPEUTICS INC | $0 | – | -610,083 | -100.0% | -0.24% | – |
| RNA | Exit | AVIDITY BIOSCIENCES INC | $0 | – | -300,000 | -100.0% | -0.28% | – |
| PTGX | Exit | PROTAGONIST THERAPEUTICS INC | $0 | – | -871,493 | -100.0% | -0.40% | – |
| SNDX | Exit | SYNDAX PHARMACEUTICALS INC | $0 | – | -500,000 | -100.0% | -0.53% | – |
| CRNX | Exit | CRINETICS PHARMACEUTICALS IN | $0 | – | -1,048,829 | -100.0% | -0.81% | – |
| BMRN | Exit | BIOMARIN PHARMACEUTICAL INC | $0 | – | -189,800 | -100.0% | -0.82% | – |
| ESPR | Exit | ESPERION THERAPEUTICS INC NE | $0 | – | -4,000,000 | -100.0% | -1.05% | – |
| ASND | Exit | ASCENDIS PHARMA A/Scall | $0 | – | -249,300 | -100.0% | -1.28% | – |
| ALBO | Exit | ALBIREO PHARMA INC | $0 | – | -1,704,000 | -100.0% | -1.55% | – |
| HZNP | Exit | HORIZON THERAPEUTICS PUB Lput | $0 | – | -500,000 | -100.0% | -2.39% | – |
| HZNP | Exit | HORIZON THERAPEUTICS PUB L | $0 | – | -500,000 | -100.0% | -2.39% | – |
| SRPT | Exit | SAREPTA THERAPEUTICS INC | $0 | – | -528,244 | -100.0% | -2.87% | – |
| ASND | Exit | ASCENDIS PHARMA A/Ssponsored adr | $0 | – | -700,000 | -100.0% | -3.59% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| JAZZ PHARMACEUTICALS PLC | 8 | Q3 2023 | 7.2% |
| TRAVERE THERAPEUTICS INC | 8 | Q3 2023 | 5.7% |
| IMMUNOVANT INC | 8 | Q3 2023 | 7.2% |
| BICYCLE THERAPEUTICS PLC | 8 | Q3 2023 | 5.2% |
| BEAM THERAPEUTICS INC | 8 | Q3 2023 | 3.9% |
| 4D MOLECULAR THERAPEUTICS IN | 8 | Q3 2023 | 2.9% |
| REPARE THERAPEUTICS INC | 8 | Q3 2023 | 3.1% |
| VIRIDIAN THERAPEUTICS INC | 8 | Q3 2023 | 2.2% |
| DYNE THERAPEUTICS INC | 8 | Q3 2023 | 2.2% |
| SILENCE THERAPEUTICS PLC | 8 | Q3 2023 | 1.6% |
View Deep Track Capital, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Orchard Therapeutics plc | March 20, 2023 | 19,125,150 | 10.0% |
| ARDELYX, INC.Sold out | February 14, 2023 | 0 | 0.0% |
| ASSEMBLY BIOSCIENCES, INC. | February 14, 2023 | 1,833,437 | 3.8% |
| Aurinia Pharmaceuticals Inc. | February 14, 2023 | 324,238 | 0.2% |
| CHINOOK THERAPEUTICS, INC. | February 14, 2023 | 3,000,000 | 4.7% |
| Forma Therapeutics Holdings, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Global Blood Therapeutics, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| HOOKIPA Pharma Inc. | February 14, 2023 | 1,240,369 | 2.4% |
| KalVista Pharmaceuticals, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Keros Therapeutics, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
View Deep Track Capital, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-04-22 |
| SC 13G | 2024-04-12 |
| SC 13G | 2024-04-05 |
| SC 13G | 2024-03-22 |
| SC 13G | 2024-03-22 |
| SC 13G | 2024-03-22 |
| SC 13G | 2024-03-15 |
| 3 | 2024-03-14 |
| SC 13G | 2024-03-08 |
| SC 13G | 2024-02-23 |
View Deep Track Capital, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.